FDA issues an emergency use authorization for Mercks molnupiravir to treat mild-to-moderate Covid-19 in some adults.
Padagis recalls three lots of 12 g spray bottles of nitroglycerin lingual spray labeled for Perrigo due to the potential for a defective dispenser.
FDA grants an emergency use authorization for Pfizers Paxlovid, the first oral treatment for some Covid-19 cases.
FDA Review posts the following Federal Register notices that published during our annual holiday break (12/20-12/30).
FDA Review posts product approval summaries for the week ending 12/31/2021.
FDA says the Baxter Healthcare recall of its Volara system due to risk of respiratory distress in home use is Class 1.
New York University bioethicist Arthur Caplan says those calling for greater diversity in clinical trials should clearly explain the benefits of such ...